Contact Us
UBC Insights

Insights from
UBC's Expert Voices

Featured Updates

Featured Image
Blog
November 2, 2026 19 min read

From Patient-Reported Outcomes to Personalized Outcomes: How the Patient’s Voice is Emerging in Drug Development
Drug development has moved from measuring disease to measuring how patients feel and function. The next question is whether we are measuring what matters most to each individual patient.
Featured Image
Blog
October 22, 2026 8 min read

Inspection Readiness Is a Mindset, Not a Moment
Ask most people what inspection readiness means and you’ll hear about a scramble: pulling documents together, briefing colleagues, running mock inspections in the weeks before the real thing. That picture isn’t wrong, it’s just incomplete, and it puts the emphasis in the wrong place.
Tom Coles
Director, Pharmacovigilance
Featured Image
Blog
October 19, 2026 11 min read

Beyond Static Reports: How Real-Time Safety Dashboards Are Changing Client Conversations
When the only view of the program is a static snapshot, the honest answer is often “we’ll know when the next report comes in.” That is the gap real-time dashboards close.
Anshika Arora
Lead Data Analyst, UBC Analytics

Posts by Date

Two women in a professional setting, one smiling while looking down, suggesting collaboration or discussion.
Blog
April 15, 2025 7 min read

Evolving PV Landscape: Artificial Intelligence and Advanced Gene Therapy
UBC Pharmacovigilance experts, Dobrochna Dolicka, Christopher Henry, Alix Garcia and Irene Navarro presented at DIA Europe 2025 on how AI can be used to streamline pharmacovigilance activities and how harmonization of guidelines can be enhanced in order to define a specific framework for gene therapy.
A woman in glasses and a blazer speaks to a person, writing on a tablet during a consultation or interview.
Blog
April 4, 2025 16 min read

Unlocking the Potential of Psychedelic Therapies
Psychedelic-assisted therapies are starting to emerge with potential as treatments for mental health conditions. Explore the evidence behind an increased interest in this use of substances such as psilocybin, MDMA, LSD, and DMT, and the future of research in this area.
Catherine Miller, MSN, CRNP, FNP-BC
Senior Project Manager, Safety, Epidemiology, Registries and Risk Management
A close-up of two hands, one gently holding the other, resting on white bedsheets, conveying comfort and support.
Blog
March 4, 2025 6 min read

The Crucial Role of Adherence Support for Patients Prescribed a High-Cost Injectable or Infusion Therapy
Adherence is critical to ensuring patients receive full therapeutic benefit and effectively manage their disease, particularly for complex treatments such as injectables or infusions. Explore strategies to support patients and improve adherence in the blog.
Marci Gott
Executive Director, Patient Services
An Asian businesswoman writing on a whiteboard uring conference meeting
Blog
February 4, 2025 17 min read

Global Risk Management and Risk Evaluation and Mitigation Strategy (REMS) Developments in 2024 and Considerations for 2025
Dive deep on a number of developments occurred during 2024 that will drive considerations in risk management and REMS for 2025 and beyond.
Two women walk across a large, modern lobby with dark marble floors, flanked by wooden slatted walls and stairs.
Blog
December 4, 2024 7 min read

Driving Program Awareness through Stakeholder Collaboration
This article explores strategies to enhance Patient Service Programs (PSPs) awareness through digital engagement and provider collaboration.
A man with glasses and a beard sits on a couch, looking down at a laptop in front of him. He is wearing a light-colored shirt.
Blog
November 11, 2024 4 min read

Standardization and the Evolving REMS Landscape
Learn about the FDA's new guidance, the challenges of standardization, and how UBC is driving innovation in REMS implementation using modern APIs from UBC's VP of Data Intelligence and Program Analytics, Jim Shamp.
A person with an IV in their arm uses a smartphone while sitting in a chair, focusing on the technology.
Blog
November 1, 2024 4 min read

The Evolution of Patient Support for Cell and Gene Therapy Products
Discover UBC's insights from the Cell & Gene Meeting on the Mesa, the unique challenges patients face, and the importance of tailored support services to ensure successful treatment journeys
A person in white gloves loads blood sample tubes with yellow caps and barcodes into a laboratory machine for analysis.
Blog
October 23, 2024 7 min read

The impact of CKD: Why better, accessible treatments and diagnostics are crucial
Supporting National Kidney Week 2024
A young man at home on a call with his patient services case manager
Blog
October 14, 2024 1 min read

Podcast | Boosting Patient Adherence: The Power of Clinical Support Programs
UBC talked to Pharmaceutical Commerce about what artificial intelligence capabilities could do to impact patient access in 2024 and beyond.
1 … 5 6 7 8 9 … 21

Press Inquires

UBC logo white

Thank You for Connecting with UBC

.

 

Return to Homepage
Connect with Us on LinkedIn
UBC logo white

Service Request

Bekki Bracken Brown Headshot

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.